January 26, 2010
The marketing team sued over a drug’s alleged side effects tried to suppress key data, an ex-employee has claimed.
Seroquel’s former UK medical adviser told the BBC he was pressured to approve promotional material which said weight gain was not an issue.
Maker AstraZeneca, which faces fresh legal action next month, said it took concerns about its conduct seriously.
In the same programme, the British Medical Journal editor urged that the medicine licensing system be reviewed.
Dr Fiona Godlee said industry should no longer provide the evaluations of its own drugs which the licensing body considered.
Thousands of patients are suing AstraZeneca in US courts, claiming the anti-psychotic drug Seroquel caused weight gain and diabetes.
The patients allege Seroquel, its second biggest selling drug worth $4.5bn (£2.7bn) a year, was marketed without adequate warning about possible side effects such as massive weight gain and the development of diabetes. However, this is denied by the company.
Read entire article: http://news.bbc.co.uk/2/hi/health/8478924.stm
SHARE YOUR STORY/COMMENT